Connect with us

Health

CDC’s ‘Universal’ Recommendations for Infant Hep B Vaccine Not Based on Science, But Assumptions (Part 3)

Published

on

Putting the majority of U.S. children at unnecessary risk of neurodevelopmental injury with incalculable costs to society.

advertisement - learn more

[Note: This is the last installment of a three-part Hep B series examining the CDC’s rationale for its universal infant hepatitis B vaccination recommendation. Part 1 explores the risk to infants of a Hepatitis B infection. (The vast majority of children in the US today are not at significant risk of hepatitis B infection.) Part 2 reveals how the agency began recommending vaccination for pregnant women and infants despite a complete lack of randomized, placebo-controlled trials demonstrating that these practices are safe. Part 3 examines the CDC’s 1991 policy shift to recommending that infants be ‘universally’ vaccinated, typically on the first day of their lives, thus placing millions of children at unnecessary risk of neurodevelopmental harm from the vaccine. Read the full series.]

Given the low risk to most newborns of Hepatitis B infection, the routine screening during pregnancy to identify at-risk newborns and the availability of HBIG treatment for exposed infants (that is 75 percent effective at preventing chronic infection), coupled with the lack of studies to determine the safety of vaccinating pregnant women and infants, what was the scientific medical rationale underlying the CDC’s decision in 1991 to recommend that all newborn babies be vaccinated?

The simple answer is that there wasn’t one. The ACIP’s recommendation was not based on science, but on the CDC’s desire to achieve its goal of eliminating transmission of HBV by achieving high vaccination rates. Indeed, the CDC was actually quite explicit about this at the time.

The stated reason why the CDC wanted to vaccinate all infants was not because all infants were at risk of infection, but simply because its strategy to vaccinate high-risk populations was failing.

The CDC’s “rationale for a comprehensive strategy to eliminate transmission of hepatitis B virus in the United States” was published in its journal Morbidity and Mortality Weekly Report (MMWR) on November 22, 1991. The new strategy included “making hepatitis B vaccine part of routine vaccination schedules for all infants.” The stated reason why the CDC wanted to vaccinate all infants was not because all infants were at risk of infection, but simply because its strategy to vaccinate high-risk populations was failing.

advertisement - learn more

In the CDC’s own words, “In the United States, most infections occur among adults and adolescents. The recommended strategy for preventing these infections has been the selective vaccination of persons with identified risk factors. However, the strategy has not lowered the incidence of hepatitis B, primarily because vaccinating persons engaged in high-risk behaviors, life-styles, or occupations before they become infected generally has not been feasible.” (Emphasis added.)

As the CDC reiterated, “Efforts to vaccinate persons in the major risk groups have had limited success.” Furthermore, “Educational efforts alone are not likely to fully eliminate the high-risk behaviors responsible for HBV transmission.”

Infants, of course, do not engage in those high-risk behaviors. The CDC’s reasoning was simply that, since adults tended for various reasons to not to get the vaccine, it would eliminate the choice by vaccinating everyone at birth, regardless of individual risk.

It would be cheaper and easier, the CDC argued, just to vaccinate everyone at birth than to continue targeting high-risk populations. “In the long term,” the CDC judged, “universal infant vaccination would eliminate the need for vaccinating adolescents and high-risk adults.”

Continuing, the CDC noted that the older, plasma-derived vaccine was no longer produced in the US, having been replaced by the recombinant vaccine technology. Like the older vaccine, both brands of the newer HepB vaccine contained aluminum and mercury.

The CDC acknowledged that no long-term studies had been done to determine the effectiveness of the new vaccine. Instead, its effectiveness was judged on the basis of studies done for the older, plasma-derived vaccine. With the older vaccine, protective antibody levels were initially provoked in most subjects, but waned over time so that after nine years as many as 60 percent of subjects no longer had detectable antibodies. However, the vaccine seemed to induce immunologic memory so that subjects remained immune despite waning antibody titers. For children vaccinated at birth, the protective effect of the vaccine persisted for “at least 5 years”.

Hence, the CDC’s recommendation was not based on scientific studies demonstrating that the recombinant HepB vaccine administered in early childhood would confer immunity throughout adulthood. Instead, the CDC’s policy was faith-based, resting on the mere assumption that it would do so.

… it’s very easy to say that there is no apparent evidence of harm when studies to determine the risk have not been done.

The CDC’s new policy was even more faith-based when it came to the question of the new vaccine’s safety. It produced no studies demonstrating that exposing fetuses and infants to these neurotoxins was safe. Instead, citing its own unpublished data, the CDC judged on the basis of “limited experience” that there was “no apparent risk” to developing fetuses of vaccinating pregnant women. Of course, it’s very easy to say that there is no apparent evidence of harm when studies to determine the risk have not been done.

The CDC also once again employed the non sequitur fallacy that, since the viral antigen particles in the vaccine were noninfectious, the vaccine “should cause no risk to the fetus”—thus once again demonstrating the institutionalized failure to consider the potential for neurodevelopmental harms from mercury and aluminum.

Beyond that, the best the CDC could do to reassure the public about the vaccine’s safety was to add that “Hepatitis B vaccines have been shown to be safe when administered to both adults and children. Over 4 million adults have been vaccinated in the United States, and at least that many children have received hepatitis B vaccine worldwide.”

Of course, this, too, was a non sequitur fallacy, as the conclusion that the vaccine is safe does not follow from the premise that it had been injected into four million children globally. (Consider how many cigarette smokers there must have been in the world already before the government and tobacco industry finally acknowledged that smoking can cause lung cancer.)

In the CDC’s faith-based judgment, the benefit of possibly preventing an estimated 2,000 to 5,000 annual deaths from HBV-related liver disease outweighed any potential harms, including the risks of unnecessarily exposing millions of fetuses and newborn babies to the neurotoxic effects of mercury and aluminum.

In 1999, the decision was made to eliminate the mercury-based preservative thimerosal from most vaccines routinely recommended for children. This was done because it had become known that the CDC’s schedule was exposing children to cumulative levels of mercury that exceeded the safety guidelines of the US Environmental Protection Agency (EPA). However, thimerosal is still used in multi-dose vials of influenza vaccines, and both hepatitis B vaccines licensed for use in infants still contain aluminum.

Evidence of Neurological Harm from the HepB Vaccine

Despite widespread concerns about the possibility of neurodevelopmental harm from the HepB vaccine, which is administered to more than 70 percent of newborns worldwide, still twenty-five years after the CDC implemented its universal infant vaccination regimen, as a team of Chinese researchers noted in a study published in the journal Psychoneuroendocrinology, “Whether this neonatal vaccination affects brain development is unknown.”

previous study by the same team, published in the Journal of Neuroimmunology a year prior (2015), was the first to examine the question of “whether neonatal vaccination could influence brain development in a physiological manner.” Studying the effects of vaccination in rats, among their findings was that it triggered an increase in “pro-inflammatory cytokines, such as IL-1β, IL-6, and TNF-α”, which research had focused on “as having a detrimental effect on neuronal function and synaptic plasticity.” The increase in pro-inflammatory cytokines was part of “a neurotoxic expression profile” exhibited by HepB-vaccinated rats. Their data confirmed “that altered immune status induced by vaccination modulates hippocampal synaptic plasticity during early life”. The vaccine induced a bias toward an antibody response, or humoral immunity, in relation to cell-mediated immunity. This skewing of the immune system, they concluded, “exerted detrimental effects”.

… early vaccination with [hepatitis B vaccine], which induces strong immune activation, is suspected to influence brain development and behavior.

In their study the following year, the researchers elaborated: “Perinatal immune activation has been demonstrated to influence brain development and behavior. The brain is still developing in the early postnatal time period and thus immune activation can impact the developmental programming of the brain. . . . Therefore, early vaccination with [hepatitis B vaccine], which induces strong immune activation, is suspected to influence brain development and behavior.”

Furthermore, the balance between cell-mediated (Th1) and humoral immunity (Th2) “serves as an important mediator for the effects of immune activation on the central nervous system (CNS).” The HepB vaccine, as previously reported, induced a Th2 bias, which “is regarded as neurodetrimental” and “has been reported to be associated with cognitive deficits”. Their new study demonstrated that early HepB vaccination impaired the behavior, the synaptic plasticity of the hippocampal part of the brain, and the growth of nerve tissue of mice in early adulthood. These detrimental outcomes were all possible effects of “the alterations in the brain neuroimmune milieu following the systemic Th2 bias.”

The researchers concluded that early HepB vaccination “induces impairments in behavior and hippocampal neurogenesis”, with their data “supporting the long suspected potential association of [hepatitis B vaccine] with certain neuropsychiatric disorders such as autism and multiple sclerosis.”

In a third rodent study published in the journal Cytokine in October 2018, the researchers highlighted how HepB vaccination “induced an instant anti-inflammatory cytokine response and a subsequent proinflammatory cytokine response in the hippocampus.” Notably, behavioral impairment appeared in mice vaccinated on the day of their birth at eight weeks of age, coinciding with “the delayed hippocampal neuroinflammation”. A dramatic increase in pro-inflammatory cytokine levels (IL-1β, IL-6, and TNF-α) as compared to controls was observed between thirty-five to forty-two days post-vaccination.

Naturally, such evidence of delayed neurological harm couldn’t possibly have been detected in the uncontrolled clinical trials with only four or five days of follow-up that were used by Merck and GlaxoSmithKline to obtain the FDA’s stamp of approval for getting their products to market.

As Children’s Health Defense contributing writer J.B. Handley has remarked with respect to this series of studies, “It’s reasonable to say that the way Hepatitis B vaccine was tested and the way Hepatitis B causes brain damage (on a delayed schedule) means our health authorities have no idea how much brain damage Hepatitis B vaccine is causing our children. None.”

Conclusion

While public health officials and the corporate news media mock and scorn anyone who dares to question the wisdom of vaccinating children strictly according to the CDC’s recommended childhood schedule, including vaccination of newborn babies on the very first day of their lives, what the science is telling us is that there are very legitimate reasons for concern. At the very least, there ought to be open discussion and debate about the practice of vaccination, yet instead we are witnessing a concerted effort to silence critics and more strictly enforce vaccine mandates required for school entrance.

While we’re told that the hepatitis B vaccine is a “crucial shot” for infants, the reality is that the vast majority of children are not at significant risk of infection. The CDC’s recommendation to vaccinate newborns universally was not based on science, but on the assumptions that the vaccine would effectively reduce HBV-related liver disease mortality and—to paraphrase the words of FDA microbiologist Richard Daemer—would be incapable of causing harm to pregnant women’s developing fetuses or newborn babies.

Instead, what science is telling us is that the CDC’s recommendation to universally vaccinate newborns at birth puts the majority of children in the US at a completely unnecessary risk of neurodevelopmental harm from the hepatitis B vaccine, with incalculable costs to society.

Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Advertisement
advertisement - learn more

Alternative News

Investigation Shows The MMR Vaccine Was Approved Based On Small Studies Showing Disturbing Results

Published

on

In Brief

  • The Facts:

    A FOIA request by Del Bigtree reveals that the 8 studies supporting the release of the MMR vaccine were only 6 weeks long, used only 800 children, and led to damaging respiratory and gastrointestinal illnesses to many of the children.

  • Reflect On:

    Are we ready to collectively deal with the implications of ongoing revelations of industry malfeasance with regards to vaccines that for some may require a shift in long-held beliefs?

Amidst a rash of efforts to bring forward mandatory vaccination in pockets of the United States is the recent move in New York City to declare a public health emergency Tuesday over a measles outbreak and order mandatory vaccinations in one neighborhood for people who may have been exposed to the virus.

Mayor Bill de Blasio announced the unusual order to address what he said was a measles “crisis” in Brooklyn’s Williamsburg section, where more than 250 people have gotten measles since September. The order applies to anyone living, working or going to school in four zip codes in the neighborhood. The declaration requires all unvaccinated people who may have been exposed to the virus to get the vaccine, including children over 6 months old. People who ignore the order could be fined $1,000.

Challenging Assumptions

This kind of invasive move gives rise to several serious questions, including challenging many of the assumptions that are necessarily made to justify such a move.

Assumption #1: People who may have been infected with the measles should get vaccinated immediately. De Blasio wants people who may have been infected with the measles to get vaccinated. The assumption here is that the vaccine would actually help someone who has the virus by preventing them from getting the measles or preventing them from spreading it to others. But this just doesn’t stand to reason. If someone is already infected, getting a measles vaccine will not prevent the outbreak. That’s not what a vaccine is designed for. And while the person is going through the 2-week period it takes for the vaccine to take hold, it’s quite possible that this will weaken the immune response to the actual measles infection the person has. Quarantining people suspected of being infected would be the sensible response, not vaccinating. If they happen to have the measles, no problem. Once they recover they will then be immune for life.

Assumption #2: The MMR Vaccine Can Create Herd Immunity. There is an article in the Huffington post entitled ‘I’m No Anti-Vaxxer, But the Measles Vaccine Can’t Prevent Outbreaks,’ in which Dr. Gregory Poland, who strongly advocates for vaccines, notes that outbreaks are often initiated and spread by people who have been fully vaccinated against the measles–over 50% in the case of a 2011 outbreak in Quebec. How is this possible? While this Quebec outbreak happened within a community that supposedly had achieved herd-immunity status of over 95% vaccinated, the facts are, as the article notes, that “9 per cent of children having two doses of the vaccine, as public health authorities now recommend, will have lost their immunity after just seven and a half years. As more time passes, more lose their immunity.” Therefore, herd immunity for measles is simply impossible to achieve with this vaccine.

advertisement - learn more

Assumption #3: The MMR Vaccine, in de Blasio’s words, is ‘safe, effective, and life-saving.’ The claim that the MMR vaccine is ‘life-saving’ does not stand up to simple statistics, as we detail in our article ‘Statistics Show The MMR Vaccine Kills More People Than The Measles Does.’ Whether it is effective, we have already seen that it is incapable of creating herd immunity, wanes over time, does not work at all for some people, and in some of the latest outbreaks the majority of people infected were fully vaccinated. Is it safe? This is the important question we cover in the next section.

The Studies That Stand Behind The Approval Of the MMR Vaccine

The pharmaceutical industry, as well as governmental regulatory bodies like the CDC and the FDA, assure the public that they take the safety of vaccines seriously, and that there is irrefutable science behind the notion that vaccines are safe in terms of the studies that their approval is based on.

However, a Freedom of Information Act request by Del Bigtree has revealed absolutely startling information about the studies that supported the approval of the MMR vaccines that have been injected into our children. To begin with, only 8 studies were conducted and the total combined number of children participating in the studies was only a little over 800! Furthermore, the studies only recorded symptoms for the first 6 weeks after the vaccines were given, unlike many other drug studies that follow symptoms for 5 years or more. And finally, the study revealed serious side-effects in those receiving the vaccine, including a highly significant number of participants who suffered upper respiratory illness and gastrointestinal illness, which has been linked to autism.

In our latest episode of The Collective Evolution Show on CETV, Joe, Arjun and I discussed New York’s mandatory vaccination order as well as Del Bigtree’s analysis of the MMR studies he received and the reason that Big Pharma not only does not want to do proper, large-scale studies on the safety of vaccines, but they also want to try to prevent other researchers like Dr. Christopher Exley from doing so as well.

You can watch the full episode of The Collective Evolution Show where we talk about this subject in more detail here.

You can go here to see the full episode of ‘The Highwire’ where Del Bigtree breaks down the MMR studies in question.

The Takeaway

The veils of illusion that have been masking the truth are lifting as our consciousness awakens. Transparency is coming, though how long it takes will depend on our continued efforts to dig for and spread the truth far and wide.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Alternative News

Merck’s Julie Gerberding Wins Industry ‘Woman Of The Year’ Award For Putting Profits Ahead Of Human Health

Published

on

In Brief

  • The Facts:

    Julie Gerberding, the Healthcare Businesswomen’s Association 'Woman of the Year,' is a prime example of someone who has gone through the revolving door between government regulatory agencies and the corporations they are supposed to be regulating.

  • Reflect On:

    It is becoming clear that our authorities in government and business alike are making decisions purely for their own interests, in utter disregard for human safety and well-being. How does this realization play a role in our awakening?

If you are not already clear about how the Corporatocracy that we live in is able to consistently serve their own power and wealth interests at the expense of our heath, well-being and prosperity, then the case of Julie Gerberding should provide some excellent insight. Her career path makes her the poster child for people who want to succeed in the world by embracing the corrupt, deceitful system that is currently in place.

Here is the blueprint: first, become an expert in a very specific area through a good old fashioned Western education. Use the talent and intelligence you have been blessed with to move up the ranks in your chosen industry to gain a position of power within the highest government agency in your field. Work in close collaboration with the corporations you are supposed to be the watchdogs for, and display a particular talent to get away with murder, not only deflecting obvious conflicts of interest and preventing them from materializing into lawsuits, but also demonstrating a highly developed ability–and willingness–to garner public trust around the safety and effectiveness of the products being pushed by the corporations you are colluding with.

Julie Gerberding

Julie Gerberding completed her internship and residency in internal medicine at UCSF, where she also served as Chief Medical Resident before completing her fellowship in Clinical Pharmacology and Infectious Diseases. She earned an M.P.H. degree at the University of California, Berkeley in 1990.

Before becoming CDC Director and ATSDR Administrator, Gerberding was Acting Deputy Director of the National Center for Infectious Diseases (NCID). She joined CDC in 1998 as Director of the Division of Healthcare Quality Promotion, NCID, where she developed CDC’s patient safety initiatives and other programs to prevent infections, antimicrobial resistance, and medical errors in healthcare settings.

But it is perhaps her talent in knowing how to speak with quiet authority, and a persona that people felt they could trust, that not only helped her rise up in the ranks of the government’s regulatory bodies, but also made giants of the corporatocracy take notice and treat her as one of their own. Knowing how to appeal to people emotionally, with eloquence and persuasion, is something you cannot force, nor can you teach it. Some people just have that power. What they decide to do with it is another matter.

Less than a year after she resigned from her CDC post in in January 2009, she was hired as president of Merck’s vaccine division. Now we can look at the low-hanging fruit and remark that during her tenure at the CDC, Merck became the manufacturer of 14 of the 17 vaccines ‘recommended’ for children by the CDC, and 9 of the 10 vaccines ‘recommended’ for adults by the CDC. The conflict of interest here is beyond obvious, and one would be reasonable to assume that this appointment, which garnered over $5 million in stock options alone, amounted to payback for favors done to Merck while head of the CDC.

advertisement - learn more

But I believe Merck saw genuine value in the type of leadership Gerberding brought to the table: a cold and calculating devotion to the bottom line, covered over by a veneer of compassion-like-symptoms and a trustworthy tone of authority. In the pharmaceutical industry, these qualities are gold.

CNN Interview

During our bi-weekly broadcast on CETV, Joe Martino and I had a discussion about the ‘revolving door’ between government regulatory agencies and the corporations they serve. We look at statistics that would literally make your head spin about the hordes of people who have enjoyed the freedom to move from working on one side of the aisle to the other. Typically this pattern serves those willing to ‘play ball’ with corporate powers in their capacity as government regulators, to then be rewarded by the wealthy corporations with cushy jobs and board appointments.

In the case of Julie Gerberding, we dove deep into a CNN interview Gerberding did with Sanjay Gupta while she was at the CDC around the time that the Hannah Poling case was making headlines and getting widespread public attention. (Hannah Poling was the first child to receive money from the National Vaccine Injury Compensation Program for her vaccine injury; in essence, the government conceded that vaccines caused Hannah Poling’s autism). Big Pharma seemed to be in need of a reassuring voice directed at the public to prevent a massive exodus of parents from the growing vaccine schedules being lined up for their children.

Joe and I talked about the various techniques Gerberding uses to deftly move the conversation from a very vague ‘admission’ of what the government had conceded to assurances that all caring parents should continue to have their children vaccinated.

By some accounts, Julie Gerberding had a significant impact at this time in preventing a complete loss in confidence in vaccine safety, which would have been a major disaster for the pharmaceutical industry. Makes you wonder why she didn’t win the Healthcare Businesswomen’s Association ‘Woman of the Year’ award sooner.

The Takeaway

As difficult as it is for some of us to accept, the belief that those in authority have humanity’s best interests at heart has long run its course. It is an important part of our collective evolution that we realize we cannot count on our elected officials, corporate leaders, bureaucrats or other authority figures to make decisions that are in our best interests, because by and large we are seeing that they are only making decisions in their own interests, for the expansion and consolidation of their power. As individuals we must seek to become sovereigns, and as sovereigns to link together and awaken to our collective power to consciously create the type of world we really want to live in.

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading

Alternative News

Legal Challenge Against Forced Vaccination Filed in New York City

Published

on

On April 15, 2019, a legal challenge was filed in the New York State Trial Court by Robert Krakow, Robert F. Kennedy, Jr. and Patricia Finn against the New York City Department of Health and Human Hygiene for their forced Measles-Mumps-Rubella vaccination. The legal team asked for a temporary restraining order against the mandate that the Judge will likely review and provide an ex parte decision. Children’s Health Defense is supporting these efforts.

Last week, Children’s Health Defense reported that the NYC Commissioner of Health declared a public health emergency, ordering all people who live, work or reside in four Brooklyn zip codes to be vaccinated with the Measles-Mumps-Rubella vaccine. Non-compliance with the order is a misdemeanor subject to criminal and civil fines, including imprisonment. Only those with documented immunity, medical contraindications or infants under six months are exempt from the vaccine mandate.

READ THE PETITION
READ THE MEMORANDUM OF LAW
READ THE AFFIRMATION

Sign up for free news and updates from Robert F. Kennedy, Jr. and the Children’s Health Defense. CHD is planning many strategies, including legal, in an effort to defend the health of our children and obtain justice for those already injured. Your support is essential to CHD’s successful mission.

advertisement - learn more

Help Support Collective Evolution

The demand for Collective Evolution's content is bigger than ever, except ad agencies and social media keep cutting our revenues. This is making it hard for us to continue.

In order to stay truly independent, we need your help. We are not going to put up paywalls on this website, as we want to get our info out far and wide. For as little as $3 a month, you can help keep CE alive!

SUPPORT CE HERE!

cards

Continue Reading
advertisement - learn more
advertisement - learn more

Video

Pod